XVIVO PERFUSION AB NPVXVIVO PERFUSION AB NPVXVIVO PERFUSION AB NPV

XVIVO PERFUSION AB NPV

No trades
See on Supercharts

Price target

539.830.000.00%
The 6 analysts offering 1 year price forecasts for 0RKL have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to 0RKL in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


0RKL EPS for the last quarter is 2.75 SEK despite the estimation of 0.83 SEK. In the next quarter EPS is expected to reach 1.41 SEK. Track more of XVIVO PERFUSION AB NPV financials and stay on top of what is up with the company.
In the next quarter XVIVO PERFUSION AB NPV revenue is expected to reach ‪219.49 M‬ SEK. Check out XVIVO PERFUSION AB NPV revenue and earnings and make informed decisions.
According to analysts, 0RKL price target is 539.83 SEK with a max estimate of 584.00 SEK and a min estimate of 480.00 SEK. Check if this forecast comes true in a year, meanwhile watch XVIVO PERFUSION AB NPV stock price chart and keep track of the current situation with 0RKL news and stock market news.
We've gathered opinions of 5 analysts rating 0RKL stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.